Conference - Events
Featured Events
The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modeling. With only 5% of cancer drugs successfully advancing to clinical trials, there is a critical need for more accurate and predictive models to guide therapeutic development.
For the first time, the Tumour Models Summit Nordics unites pharma, biotech, and research leaders across the thriving Nordic biotech ecosystem to tackle this challenge head-on. As the region's only industry-led event of its kind, this summit provides a rare opportunity to connect with top experts in preclinical and translational research.
Gain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling, discover strategies to de-risk your studies, and learn how to refine…
Understanding the patient's perspective is essential to driving the success of clinical trials, accelerating regulatory approvals, and enhancing the patient experience throughout their healthcare journey. Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become more critical than ever to establish quantitative measures for assessing the impact of these initiatives.
Despite this, a standardized approach to measuring the success of patient engagement strategies has yet to emerge. While patient affairs professionals recognize that meaningful engagement leads to treatments that better align with the needs of patients, th…
Events
2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T, CDR-Life, and TScan, along with a wealth of investment and partnerships amounting to over $700M, it's time to come together to relish in these breakthroughs, while pouring this energy into expanding TCR treatment potential.
The 6th TCR-Based Therapies Summit returns as the only TCR-specific platform for industry experts to join forces to share the technical insights to transform discovery, translation, R and D, and clinical development for cell- and biologic-based approaches.
Providing an unmatched close-knit collaboration environment created specifically with and for the TCR community to connect, and learn from lead…
With Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide continuing its phase 3 journey, and Chugai advancing peptides into the intracellular space, peptide therapeutics are firmly back on the map as the next modality disrupting drug discovery and development.
This includes exploring peptide structure prediction using AI/ML technologies, designing orally bioavailable and cell membrane-permeable peptides using structure-based molecular design, harnessing mRNA display and DNA-encoded libraries for peptide discovery, optimizing peptide synthesis, integrating formulation considerations at the discovery stage, and investigating peptides as drug delivery vehicles.
The 2nd Peptide-Based Therapeutics Summit returns to Boston as your most comp…
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery or emergency use, nasal delivery is opening a new era of more efficient drug and vaccine administration with life-saving potential. However, challenges in biologics formulation, along with renewed interest from major pharmaceutical companies and investors, raise questions about how other companies are addressing development obstacles and the most effective strategies to secure funding.
Dedicated to navigating investment pathways for nasal companies, boosting drug bioavailability in target regions, optimizing translational modelling, and determining the efficacy of delivery devices, the 3rd Nasal Formulation and De…
Unlock the full potential of your alliances at the 16th Strategic Alliance Management conference for Pharma, where industry leaders and innovators come together to redefine the art of partnership. This year’s agenda dives deep into the lifecycle of alliances—from negotiation and deal structuring to performance monitoring and seamless termination. Explore cutting-edge tools and methodologies to measure alliance value, resolve conflicts, and optimize outcomes. Gain insights into bridging the gap between partners, tackling internal organizational challenges, and aligning strategies to expand existing deals. With a special emphasis on big-pharma and biotech perspectives, this event offers a unique platform for forward-thinking collaboration.
Attending This Premier marcus evans Eve…
Globally renowned exhibition CMEF (China International Medical Equipment Fair) is set to return this year for another successful comprehensive display of technological advancements and solutions across the entire medical industry chain.
With over four decades of expertise in its history, CMEF as a world-leading medical and health technology platform is expected to welcome 5,000 exhibitors and 310,000 professionals from over 150 countries and regions on a massive 350,000-sqm. show area.
Attendees can also maximize CMEF-GBO, a specialized international business program established by CMEF. This provides global business on-site opportunities through different in-exhibition features including the WeTalk Global Stage where companies are invited to showcase their cutting-edge products and techno…
The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modeling. With only 5% of cancer drugs successfully advancing to clinical trials, there is a critical need for more accurate and predictive models to guide therapeutic development.
For the first time, the Tumour Models Summit Nordics unites pharma, biotech, and research leaders across the thriving Nordic biotech ecosystem to tackle this challenge head-on. As the region's only industry-led event of its kind, this summit provides a rare opportunity to connect with top experts in preclinical and translational research.
Gain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling, discover strategies to de-risk your studies, and learn how to refine…
The Annual Translational Microbiome Conference continues to be an integral venue for industry, academia and government to share microbiome research and connect with colleagues in the field. This meeting showcases ground-breaking research being performed by leadings scientists from around the globe. Attendees will have the opportunity to hear the leading companies and academicians discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.
Cutting-Edge Research: Immerse yourself in the latest breakthroughs, advancements, and scientific insights in microbiome research.
Interdisciplinary Perspectives: Engage in stimulating discussions that bridge the gap betwee…
With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this delivery vehicle is truly exciting!
The 4th LNP Formulation and Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver.
With a revamped track design, the 2025 meeting has 3 dedicated streams, Analytical Development and Characterization, Formulation and Delivery and Process Development and Manufac…
19-Apr-2025 - 20-Apr-2025
INC2025 will features state-of-the-art advances in Neonatal care and research delivered through an expert panel of local and international faculty with decades of experience at leading institutes. The event will provide attendees with an opportunity to learn, debate, and network with peers in this very active scientific field.
The congress will highlight what is new in neonatology, birth complications, neonatal cardiology, neonatal endocrinology, neonatal nutrition, neonatal infection, neonatal surgery, brain injury, ventilation, neuroprotection quality, ethical issues and neonatology in future and many more other interesting topics, giving the opportunity to interact and share clinical and research experiences with colleagues in the neonatal community.
As the premier event, we have develope…
International Oncology Forum is a unique event that will reflect the crucial role of Precision Oncology, manifest the latest updates and guidelines in Breast, Lung, Gastrointestinal, Genitourinary, and Gynecological cancers.
It will highlight key advances of clinical applications of precision medicine in daily oncology practice.
International Oncology Forum will contain keynote presentations which cover new and breakthrough approaches for treating different types of cancer. It will shed light on the evolving trends of personalized and targeted therapies.
Time: 9:00 AM - 5:00 PM
It is with great pleasure that I welcome you all to the 14th MENA Health Insurance Congress 2025, which is being held in the vibrant and exciting city of Dubai. This conference will cover a wide range of topics that are of utmost importance to the healthcare industry, including value-based healthcare, universal healthcare, digital health ecosystem, healthcare underwriting, emerging trends in health insurance, health technology assessment, healthcare quality assurance and performance improvement, sustainability in healthcare, and revenue cycle management. As the healthcare industry continues to evolve and transform, it is essential for us to stay abreast of the latest trends, technologies, and best practices. This congress has been designed to provide a comprehensive and in-depth exploratio…
The Pharma CI Europe Conference & Exhibition (April 23-24, 2025) is the industry's gold standard event for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the competitive intelligence community today. This is the only event featuring a world-class lineup of speakers and panelists offering their unique insights and expertise on the topics you care about most!
The Pharma CI Conference & Exhibition is the best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices for 20+ years.
To register or for more information, please visi…
The Pharma Market Research Conference Europe (April 23-24, 2025) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices, and diagnostics. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.
This event is unlike any other conference in Europe. It’s immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.
The Pharma Market Research Conference is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years
For more information, please go to http://pharmamarket…
The Research Gate (TRG) creates an international platform for exchanging ideas and best practices in a manner that demonstrates respect for diversity and inclusion. TRG invites participants from the global healthcare community to attend the International Conference on Neuropsychiatry & Mental Health 2025 on April 24-25, 2025. This conference will feature Neurologists, Neurosurgeons, Psychiatrists, Psychologists, Neurobiologists, Neuroimmunology’s and Members from Neurology Organizations. The Neuropsychiatry & Mental Health 2025 strives to promote evidence-based strategies, increased collaboration among healthcare professionals, and increased quality of care to address the challenges of a rapidly changing healthcare environment.
26-Apr-2025 - 27-Apr-2025
The Dubai International Conference on Infectious Diseases and Vaccination (DICID) 2025 will once again bring together policymakers, regional and international experts, and healthcare professionals to share advanced research, updates, and global guidelines in the field of infectious disease prevention, diagnosis, and management. This premier event will emphasize best practices in combating microbial resistance and highlight innovative strategies for developing effective disease management and prevention plans.
Attendees will benefit from engaging presentations and thought-provoking panel discussions led by leading experts from the field, ensuring actionable insights and knowledge sharing.
Time: 9:00 AM - 5:00 PM
The 4th ADC Analytical Development Summit is returning to Boston in April 2025. This event will bring together the brightest minds in the field to address the unique analytical challenges of antibody-drug conjugates. As regulatory expectations tighten and ADCs become increasingly complex, this summit will serve as your guide to ensuring high-quality products and seamless regulatory submissions.
With the FDA’s updated ICH Q14 guidance raising the bar for release and stability testing, adopting advanced analytical methods is more critical than ever to maintain product quality. This summit offers a unique platform to explore how to meet these regulatory requirements effectively while ensuring your ADC remains robust throughout its lifecycle.
ADC developers are increasingly working with novel…
The marcus evans 13th Edition Medical Device Safety Monitoring Reporting and Surveillance conference taking place on April 28-30, 2025, in San Diego, CA, will bring together industry leaders to address key strategies for effective safety and reporting strategies. Sessions will focus on real-world data collection, adverse event reporting, and how to leverage advanced technologies like AI and data analytics to enhance safety monitoring. Attendees will gain insights into global regulatory frameworks, streamlined reporting processes, and the importance of vigilance to prevent device-related risks. Through keynote sessions, panel discussions, and workshops, the conference aims to foster collaboration and equip stakeholders with practical tools to improve safety outcomes, build patient trust, an…
Understanding the patient's perspective is essential to driving the success of clinical trials, accelerating regulatory approvals, and enhancing the patient experience throughout their healthcare journey. Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become more critical than ever to establish quantitative measures for assessing the impact of these initiatives.
Despite this, a standardized approach to measuring the success of patient engagement strategies has yet to emerge. While patient affairs professionals recognize that meaningful engagement leads to treatments that better align with the needs of patients, th…
It is no secret that GLP-1 receptor agonists have transformed the treatment of obesity and diabetes. The past 12 months have seen the GLP-1 landscape transform into something truly unrecognizable in previous years, with the global GLP-1 analogues market valued at US$47.4 billion in 2024.
With the next frontier of these blockbuster therapeutics well on its way to approval, the GLP-1 field is only going to grow, with novel combinations, indications, and formulations being explored. From MASH to Parkinson's disease, there is potential for GLP-1s to become a ‘magic bullet' across healthcare, only adding to the ever-increasing market value.
In this highly competitive market, Novo Nordisk and Eli Lilly currently lead with first-in-class GLP-1 therapies. However, the race is now focused on develo…
Empowering Community Pharmacy Congress
Innovation in Community Pharmacy Congress serves as a unique platform that gathers key stakeholders from different healthcare divisions to bridge the gap between community and hospital pharmacy and highlight the vital role of community pharmacist, not only as dispenser, but as a complete healthcare provider accessible by patients from different community sectors. Join us in this unique meeting that gathers pharmacists, academics, researchers, regulators, industry experts and healthcare professionals, to discuss the latest opportunities, innovations, advancements, and challenges within the community pharmacy all in one place for great opportunity for networking and collaboration. The congress focuses on promoting dialogue amongst stakeholders to improv…
